106 related articles for article (PubMed ID: 9179291)
1. Lipopolysaccharide binding protein from normal human plasma purified with high efficiency.
Nanbo A; Nishimura H; Nagasawa S
Protein Expr Purif; 1997 Jun; 10(1):55-60. PubMed ID: 9179291
[TBL] [Abstract][Full Text] [Related]
2. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
3. Isolation, partial characterization, and concentration in experimental sepsis of baboon lipopolysaccharide-binding protein.
Haudek SB; Natmessnig BE; Redl H; Schlag G; Hatlen LE; Tobias PS
J Lab Clin Med; 2000 Nov; 136(5):363-70. PubMed ID: 11079463
[TBL] [Abstract][Full Text] [Related]
4. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation.
Lamping N; Hoess A; Yu B; Park TC; Kirschning CJ; Pfeil D; Reuter D; Wright SD; Herrmann F; Schumann RR
J Immunol; 1996 Nov; 157(10):4648-56. PubMed ID: 8906845
[TBL] [Abstract][Full Text] [Related]
5. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14.
Yu B; Wright SD
J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
[TBL] [Abstract][Full Text] [Related]
8. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
[TBL] [Abstract][Full Text] [Related]
9. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
[TBL] [Abstract][Full Text] [Related]
10. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
11. Purification of lipopolysaccharide-binding protein from bovine serum.
Bochsler PN; Yang Z; Murphy CL; Carroll RC
Vet Immunol Immunopathol; 1996 Jun; 51(3-4):303-14. PubMed ID: 8792567
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.
Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D
J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073
[TBL] [Abstract][Full Text] [Related]
13. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation.
Hamann L; Schumann RR; Flad HD; Brade L; Rietschel ET; Ulmer AJ
Eur J Immunol; 2000 Jan; 30(1):211-6. PubMed ID: 10602043
[TBL] [Abstract][Full Text] [Related]
14. Purification of soluble CD14 fusion proteins and use in an electrochemiluminescent assay for lipopolysaccharide binding.
Burkhardt M; LopezAcosta A; Reiter K; Lopez V; Lees A
Protein Expr Purif; 2007 Jan; 51(1):96-101. PubMed ID: 16861002
[TBL] [Abstract][Full Text] [Related]
15. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.
Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K
Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777
[TBL] [Abstract][Full Text] [Related]
18. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library.
Reyes O; Vallespi MG; Garay HE; Cruz LJ; González LJ; Chinea G; Buurman W; Araña MJ
J Pept Sci; 2002 Apr; 8(4):144-50. PubMed ID: 11991204
[TBL] [Abstract][Full Text] [Related]
19. [Construction of human phage antibody library and screening and characterization of phage antibodies against N terminal fragment of human lipopolysaccharide binding protein].
Ge XD; Liu YS; Wang XD; Wang CS; Deng J; Li H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):180-4. PubMed ID: 15766403
[TBL] [Abstract][Full Text] [Related]
20. Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro.
Xu Z; Qian GS; Li Q; Feng QJ; Wu GM; Li KL
Inflamm Res; 2009 Jan; 58(1):45-53. PubMed ID: 19115038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
